The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention
Authors:
- Nilka Ríos BurrowsNBNilka Ríos Burrows
- Regina JordanRJRegina Jordan
- Desmond E. WilliamsDWDesmond E. Williams
- 1 March 2009
- journal article
- conference paper
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 53 (3) , S121-S125
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993